Bio/Data Corporation is a leading player in the Biotechnology, Health Care, Manufacturing, and Medical Devices industries. With a founding date of 1969, the company is renowned for its expertise in developing and distributing cutting-edge Platelet Aggregometers, Platelet Centrifuges, Aggregation Reagents, Consumables, and Accessories. Its extensive product range is dedicated to supporting Thrombosis, Hemostasis, and Research Laboratories globally. These products are instrumental in the meticulous evaluation of Hemostasis and Platelet Function disorders, enabling healthcare professionals and researchers to enhance their knowledge and contribute significantly to the sector.
The company's slogan "Discover Superior Performance with our Innovative Platelet Aggregometers and Aggregation Reagents!" mirrors its commitment to providing innovative testing solutions. However, specific details such as the location of its headquarters and its last investment information are not available at the moment. Nevertheless, given its extensive expertise and longstanding presence in the industry, Bio/Data Corporation presents itself as a promising potential investment opportunity for venture capitalists seeking exposure to the biotechnology and medical devices sectors.